To determine the evolution of amyloid heart disease, 28 patients with familial amyloid polyneuropathy (FAP) were studied by echocardiography. The incidence and degree of the abnormalities were correlated with the neurologic disabilities, duration of the illness, and age in cross-sectional studies. Serial studies were performed in 12 patients, who were followed for a mean of 27.7 months. At the initial examinations, left ventricular diastolic function was reduced in six patients, while systolic function was preserved in eight. On follow-up there occurred significant increases in ventricular septal wall thickness (from 10.7 + 3.1 to 13.1 + 3.2 mm; p < .01) and posterior wall thickness (from 11.8 2.5 to 13.5 + 2.3 mm; p < .01), and reductions in the E-F slope of the mitral valve (from 64.4 18.8 to 43.9 ± 1 1.0 mm/sec; p < .01), percent fractional shortening (from 36.5 + 9.4% to 28.8 + 8.2%; p < .02), and left ventricular internal diastolic dimension (from 46.2 + 6.1 to 42.4 ± 6.2 mm; p < .001). At the final examinations, marked ventricular hypertrophy was found in three patients, reduced left ventricular diastolic function in all, impaired systolic function in nine, and decreased left ventricular internal dimension in three. In addition, highly refractile myocardial echoes had appeared in two patients, pericardial effusion in three, and valve thickening in two. We conclude that amyloid heart disease in patients with FAP develops slowly but progressively.
RECENTLY many echocardiographic studies on amyloid heart diseasel-8 have been reported. Usually the cardiac involvement has been severe with gross changes including marked thickening of left and right ventricular walls, normal or decreased left ventricular internal dimension, reduced left ventricular diastolic function, and often severe abnormalities of systolic function as well as valve thickening and pericardial effusion. Furthermore, hyperrefractile myocardial echoes on the two-dimensional echocardiographic images were reported to be characteristically diagnostic of amyloid heart disease.4 5 75 To our knowledge, however, these studies have mainly been cross-sectional ones of patients with far-advanced nonhereditary primary or senile amyloidosis and amyloidosis associated with myeloma, and the natural course of cardiac amyloidosis appears not to have been investigated hitherto by serial study.
The purpose of the present study was to determine the evolution of amyloid heart disease, by means of cross-sectional and serial echocardiographic studies, in patients with familial amyloid polyneuropathy (FAP),9-'4 which is a hereditary systemic amyloidosis with chronic progression.
Methods
Subjects. During the past 8 years we examined 28 patients with FAP (14 men and 14 women, ages 33 to 67 years, mean 49.6 ± 10.2) from several locations in Nagano Prefecture12-14 in the central part of Japan. The diagnosis of FAP was based on neurologic findings and the confirmation of amyloid deposition in biopsy specimens (stomach, rectum, sural nerve, endomyocardium, skin, and kidney) or autopsy. All patients had chest roentgenographic, electrocardiographic, and both M mode and two-dimensional echocardiographic studies, and correlations between echocardiographic findings and the degree of the neurologic disabilities," duration of the illness, and age were examined. Neurologic disabilities were as follows: stage I, peripheral neuropathy limited to the lower limbs; stage II, neuropathy involving both the lower and upper limbs; stage III, bedridden because of extensively progressive neuropathy. Twelve patients (seven men and five women) were followed for 6 to 52 months HONGO and IKEDA (mean 27.7 + 13.8) and had serial echocardiographic studies.
Echocardiographic studies. The instruments used were electric sector scanners (Toshiba, model SSH-40A or SSH-1 1A Sonolayergraph with 2.4 and 3.5 MHz transducers) or a mechanical sector scanner (Aloka, model SSD-1 OS with 2.25 MHz transducer). The following variables were measured in the M mode echocardiographic study: left ventricular internal enddiastolic and end-systolic dimension, the interventricular septal wall thickness (IVST) and the left ventricular posterior wall thickness (PWT) at end-diastole, E-F slope of the anterior mitral valve, and the right ventricular anterior wall thickness at enddiastole (RVAWT). Each variable was measured according to the criteria recommended by the American Society of Echocardiography. 1 In patients whose electrocardiograms showed sinus rhythm, we also measured the maximal diastolic endocardial velocity (DEVM) of the posterior wall by the method described by Kovick et al. 16 Next, percent fractional shortening (%FS) and mean normalized velocity of circumferential fiber shortening (mVcf) were calculated. In the two-dimensional echocardiographic examination, in addition to normally discriminating cardiac structures, special attention was paid to highly refractile myocardial echoes, the so-called granular sparkling appearance, by parasternal. apical, and subxiphoid approaches. Highly refractile echoes were defined as echoes that persisted at gain settings low enough to completely eliminate the adjacent echoes.
Statistical analysis. M mode echocardiographic data in the serial studies were compared by paired and nonpaired t tests. and statistical significance was assumed when the p value was less than .05.
Results
Clinical presentation. Patients were classified neurologically as follows: stage I, nine patients; stage II, 13; and stage III, six. Duration of the illness from the onset of symptoms ranged from 4 months to 30 years (0 to 5 years, eight patients; 5 to 10 years, 13; more than 10 years, seven; mean 8.1 ± 5.6 years). Thirteen of the patients were over 50 years old. Clinically overt heart disease was absent in 15 patients, and refractory congestive heart failure and restrictive cardiomyopathy were present in only three at the initial examinations. None died of congestive heart failure during the follow-up studies. Chest roentgenographic examination revealed cardiac enlargement in seven patients and pleural effusion in three. One or more electrocardiographic abnormalities were found in 25 of the 28 patients.
Echocardiographic findings in the cross-sectional studies. As seen in tables 1, 2, and 3, the IVST, PWT, and RVAWT increased and the E-F slope, DEVM, %FS, mVcf, and left ventricular internal dimension decreased with the progression of the neurologic disabilities, duration of the illness, and age. Highly refractile granular sparkling echoes were observed in nine patients. All of them showed reductions in both the E-F slope and DEVM; %FS and mVcf were normal in five (figure 1) and abnormal in the rest. Patients who showed normal systolic function and an increased re-250 fractile pattern in the myocardium had slightly greater wall thickness (IVST, 13.4 ± 4.1 vs 9.8 ± 1.9 mm, p > .05; PWT, 13.2 ± 2.7 vs 11.1 ± 2.3 mm, p > .05) than those who exhibited normal systolic function but no refractile pattern. The incidences of the granular sparkling echoes and pericardial effusion were higher in neurologically severe, long-term, and elderly patients. No remarkable electrocardiographic finding was observed in 10 of 15 patients without clinical evidence of overt heart disease, but some echocardiographic abnormalities were present in nine of them. These included severe reduction in the E-F slope without evidence of mitral valve thickening in six patients (60%) and significant decrease in the DEVM in seven (70%), whereas the %FS and mVcf were normal in most patients and the granular sparkling appearance was observed in only one.
Echocardiographic findings in the serial studies. We followed 12 patients, 10 of whom had one follow-up study while the remaining two had two studies. Significant increases in the IVST (from 10.7 ± 3.1 to 13. 1 ± 3.2 mm; p < .0l1) and PWT (from 1 1.8 + 2.5 to 13.5 + 2.3 mm; p < .01), and reductions in the E-F 2 and 4) . The RVAWT, which could be identified in three patients, also increased from 3.7 0.5 to 4.8 + 0.2 mm. In two patients who had two follow-up studies, similar but gradual changes were observed in these variables during the first and the second studies ( figure 4 ). In four patients in whom the %FS and mVcf were normal at the initial examinations but became abnormal in their last echocardiograms, a significant reduction in the E-F slope occurred (from 63.5 5.4 to 43.0 8.5 mm/sec; p < .05) (table 4). The other three patients had normal %FS and mVcf at the final examinations. Gradual reduction in the E-F slope occurred and the mean value at that time measured 47.0 ±+ 10.7 mm/sec (table 5). The granular sparkling echoes were newly observed in two patients (figure 3). As summarized in table 6, the IVST and PWT increased and the E-F slope, %FS, and mVcf Vol. 73, No. 2, February 1986 decreased in both patients during the follow-up studies. Consequently, both had ventricular hypertrophy, severe reduction in the E-F slope, decrease in the DEVM, and abnormalities of the %FS and mVcf when highly refractile echoes were visualized. In the twodimensional echocardiographic examinations, a small amount of pericardial effusion developed in three patients ( figure 4 ) and a thickened mitral valve appeared in two, a thickened aortic valve in one, and thickened papillary muscles in three. The left atrium became enlarged in three patients and the right atrium in one.
Discussion
It is generally recognized that the cardiovascular system is commonly involved in systemic amyloidosis, usually presenting as refractory congestive heart failure.'7 '9 The diagnosis of amyloid heart disease is sometimes difficult, especially in nonhereditary cases, even after clinically significant cardiovascular symptoms occur because of marked clinical and hemodynamic similarities to other conditions such as restrictive cardiomyopathy and constrictive pericarditis. In contrast, FAP is a heredofamilial systemic amyloidosis with polyneuropathy, which shows chronic progression and variable degrees of amyloid infiltration into the heart and is thus appropriate for follow-up studies. We therefore chose this disorder to evaluate the evolution of amyloid heart disease. Autopsy findings in patients with FAP20, 21 have demonstrated that amyloid deposition was always present in the heart and that this was remarkable in the subendocardium and valves and less so in the myocardium.
In our cross-sectional studies, the incidence and degree of the echocardiographic abnormalities in FAP were generally mild or moderate when compared with those in other forms of amyloid heart disease recently described'-3 5,6 as would be expected from the fact that clinical evidence of congestive heart failure and restrictive cardiomyopathy were rarely seen and from the autopsy findings mentioned above. But in the light of the characteristic findings documented in the previous reports, the echocardiographic findings are considered to be part of a spectrum of manifestations encountered in cardiac amyloidosis.
We also found that right and left ventricular wall thickness tended to increase and the left ventricular internal dimension, %FS, mVcf, E-F slope, and DEVM tended to decrease in parallel with the progress of the neurologic disabilities, duration of the illness, and age. However, as Feigenbaum22 and Kovick et al. 16 have described, some of these abnormalities, including increased left ventricular wall thickness, decreased left ventricular internal dimension, reduction in the E-F slope, and decrease in the DEVM, are sometimes seen with aging in normal subjects. Furthermore, highly refractile myocardial echoes, which have been said to be virtually diagnostic of amyloid heart disease, 4' 4 were observed in only about one-third of the patients. Most of them were neurologically severe and had been affected for many years. These findings strongly suggest that M mode echocardiographic ab-normalities are not specific for cardiac amyloidosis and that absence of the two-dimensional granular sparkling appearance in no way rules out amyloid deposition in the myocardium, nor does its presence establish the diagnosis, since it can be seen in patients with hypertrophic cardiomyopathy and other infiltrative processes such as Pompe's disease and hemochromatosis as well as in those with chronic renal failure. 7 Serial echocardiographic studies were of value in assessing the evolution of amyloid heart disease. In our study, before clinically apparent heart disease developed, most patients without remarkable electrocardiographic changes already had some echocardiographic abnormalities. These included severe reduction in the E-F slope without evidence of mitral valve obstruction and significant decrease in the DEVM in common, whereas the %FS and mVcf were normal in most and the granular sparkling appearance was seen in only one. Thus reduction in left ventricular compliance'6 23 may be the first to develop in amyloid heart disease, although it is not possible to determine from our results whether a reduction in the E-F slope or a decrease in the DEVM is the first echocardiographic manifestation of increasing amyloid deposit. More frequent investigations on high-risk subjects or members of FAP families would perhaps clarify this problem.
Our follow-up studies lasted less than 3 years in most patients and some of them showed only slight changes during this period. However, there did occur significant increases in the IVST and PWT and reductions in the E-F slope, DEVM, %FS, mVcf, and enddiastolic dimension, and also a tendency for the RVAWT to increase. The degree of these M mode echocardiographic changes correlated generally with the follow-up period.
We attempted to analyze how well left ventricular systolic and diastolic function correlated before systol- ic abnormalities appeared. Some patients, in whom measures of systolic function were initially normal but became abnormal over time, had severe reduction in the E-F slope at the initial examinations and showed gradual decrease. Moreover, the other patients, with normal systolic performances in their last echocardiograms, had more advanced diastolic abnormalities. Thus it appears that diastolic abnormalities gradually progress and that they are already severe before the appearance of impaired systolic function. At the final examinations, we found marked ventricular hypertrophy in one-fourth of the patients, reduced left ventricular diastolic function in all, and impaired systolic function in three-fourths. Left ventricular internal dimension was decreased in one-fourth and was normal in the remainder. The granular sparkling appearance was newly observed in two patients. Their ventricular wall thickness increased and left ventricu- lar systolic and diastolic function became reduced during the follow-up studies. Subsequently, both showed ventricular hypertrophy and severe abnormalities of systolic as well as diastolic function. However, the cross-sectional studies demonstrated left ventricular diastolic abnormalities in all patients who showed granular sparkling echoes, whereas systolic function was preserved in about a half of them. Their IVST and PWT were found to be slightly greater when compared with those in patients who showed no refractile pattern in the myocardial walls, although some of the other patients had no highly refractile myocardial echo pattern in spite of mild hypertrophy and no other difference in the echocardiographic measurements. We have no explanation for the different myocardial echo pattern among patients who had mild wall hypertrophy, but the above findings show that increased wall thickness, which may be attributed to the more extensive amyloid deposition, is mainly related to the appearance of the granular sparkling echoes, even in the presence of normal systolic function. At the serial studies, it is likely that our follow-up intervals were too long, so that both patients already had systolic abnormalities when highly refractile echoes were visualized. We thus emphasize that, regardless of systolic function, granular sparkling echoes appear after wall hypertrophy with more advanced abnormalities of left ventricular diastolic function develops and that these echoes are obvious with the progression of the amyloid deposition, when ventricular walls are markedly thick-PATHOPHYSIOLOGY AND NATURAL HISTORY-AMYLOIDOSIS ened and severe abnormalities of systolic as well as diastolic function develop. Pericardial effusion and valve thickening were found in some patients whose systolic function was severely impaired. Although our experience is limited to FAP, we propose, on the basis of the results of this echocardiographic study, that the natural history of amyloid heart disease would pass through the following stages: (1) small amounts of amyloid deposition with focal thickening and resultant reduction in left ventricular compliance; (2) wall hypertrophy caused by more extensive amyloid deposition, more advanced diastolic abnormalities with preserved systolic function, and with some patients showing highly refractile myocardial echoes; (3) very marked thickening of the walls and valves, obvious granular sparkling appearance, pericardial effusion, normal or decreased left ventricular internal dimension, and marked abnormalities of systolic as well as diastolic function. It has been reported by several investigators8' 17 that some patients with amyloid heart disease had dilated ventricles. Although this finding was absent in our study, presum-Vol. 73, No. 2, February 1986 ably some patients who had other conditions such as coronary heart disease and/or chronic lung disease that might cause dilatation would go on to a subsequent stage, a picture of dilated cardiomyopathy, but with thick walls. To establish this hypothesis, further investigations of other forms of amyloid heart disease are necessary.
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